This way, patients would be able to undergo a quicker bone graft surgery with minimized inconvenience, pain, and recovery time. The Infuse Bone Graft was designed to be a replacement to the conventional idea of using donated material from the patient’s bones. In the bone graft, protein is released while replacing the degenerated bone tissue. The technique works by placing a human recombinant morphogenetic protein into a bovine collagen mold, or graft. The Infuse Bone Graft is a two-part system where bovine collagen is used to create a framework for new bone tissue to form. Infuse Bone Graft is a medical technique used to alleviate spinal problems by encouraging the natural process of bone formation. Infuse Bone Grafts have been used in millions of procedures but may have caused serious complications in many patients. & C.INFUSE Bone Graft is a procedure created by Medtronic, that employs a synthetic protein during spinal and other types of surgery to encourage new bone growth. Your name holds much respect in our family.” - G.C. The language barrier was never a problem, and we are so very thankful to them. “A special thank you to your Spanish-speaking staff for the extra effort put into this case.

Our Best Interest Was Always Number One on Your List.

“Thanks to your efforts I was able to recover from a tragic experience and turn my life around for the best.” - W.T. “The Baum, Hedlund firm has some of the top legal minds in the country they are driven, determined, trustworthy, ethical and passionate.” - From Best Lawyers® Best Law Firms They understand their role in the process of making change.” - Kim Witczak

They are about changing the systems which got us into trouble in the first place. “Baum Hedlund are not only amazing attorneys but more importantly, they are activists. “Multiple lawyers recommended Baum Hedlund to me and I have been consistently impressed with the quality of their work.” - Best Law Firms Survey The results of its review public by summer of 2012, it has yet to do so. Medtronic commissioned researchers at Yale University with a $2.5M grant to conduct an independent review of the safety andĮffectiveness of Infuse Bone Graft, including all patient data generatedĭuring the Infuse clinical trials. Pending looking into allegations that Medtronic failed to report Infuseīone Graft side effects and that the company may have had financial ties Senators Charles Grassley (R-Iowa) and Max Baucus (D-Mont.) have investigations Marketing and alleged off-label use of Infuse Bone Graft in May of 2012, Department of Justice closed its investigation into Medtronic’s Sometimes paid by Medtronic would prescribe the product for applications Sales depended on so-called “off-label” uses, where doctors That Medtronic failed to reveal that as much as 85.2 percent of Infuse According to a Reuters report, the settlement resolves claims Medtronic paid $85 million in March of 2012 to settle a shareholder lawsuitĪccusing it of making misleading statements concerning Infuse Bone Graftĭevice.The risks associated with the Infuse Bone Graft Device.

The Spine Journal, dedicated its entire journal to publishing numerous articles regarding In July of 2011, the prominent medical journal, Use is off-label according to MedPage Today. Of illegal off-label promotion and use of Infuse Bone Graft Device, financialĬonflicts of interest by researchers, under-reporting of complicationsĪnd overblown reports of superior clinical results. Medtronic has been under scrutiny for years now concerning allegations Of dollars to manipulate studies and write favorable articles on the company’s Senate Finance Committee issued a lengthy report showing that It is a recombinantīone morphogenetic protein (“BMP”) that is supposed to stimulateĬontrolled bone growth and fuse the vertebrae.

Infuse Bone Graft Device is a liquid substance producedīy a genetically engineered Chinese hamster ovary cell line. Infuse Bone Graft Device in 2002 for a limited type of spinal fusion surgery to alleviate Medical Center, on Jafter two different medical devices implantedĭuring two different back surgeries resulted in debilitating and permanentīaum Hedlund has Defeated Preemption In Ms. Originally sued Medtronic, in addition to Stryker Biotech, her doctor, and Pomona Valley Hospital Pain, Excessive Bone Growth and Other Complicationsīaum Hedlund’s first Infuse case involves back surgery patient, April Lawyers Investigate Hospitals Where Spine Surgeries Caused Patients Severe In an off-label manner, not approved by the FDA. Received the Medtronic INFUSE® Bone Graft medical device procedure This is good news for patients across the country who Lawsuit against Medtronic to move forward. Represented by Baum Hedlund Aristei & Goldman, allowing her Medtronic Infuse Bone Graft Device Lawsuit We are no longer accepting Medtronic medical device cases.Ī California state court judge ruled in favor of a California resident

Infuse bone